Why has the proposed Healius ACL merger failed and what lies next for both companies?
The Healius ACL merger appears all but dead now that the ACCC blocked the plans. Even so, it was on…
Read More
Adbri is Up 47% as CRH Plans to Takе thе Drivеr’s Sеat
The pricе-to-еarnings ratio of Adbri (ASX:ABC) is 18.8x, which is lower than the ratios of many other Australian companies, indicating…
Read More
Rhythm Biosciences (ASX:RHY): How and why did it all go wrong in 2023 and is there any way back?
Rhythm Biosciences (ASX:RHY) is back to square one after a rollercoaster 3 years. Where did it all go wrong, and…
Read More